Related Experiment Video
Updated: Mar 5, 2026

04:34
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.7K
Insomnia Treatment Preferences During Pregnancy
Summary
Pregnant women overwhelmingly prefer cognitive behavioral therapy for insomnia (CBT-I) over medication or acupuncture. This finding highlights the importance of considering patient preferences in prenatal care for sleep disturbances.
Area of Science:
- Obstetrics and Gynecology
- Sleep Medicine
- Behavioral Health
Background:
- Insomnia is a common complaint during pregnancy, affecting maternal well-being and potentially infant outcomes.
- Treatment options for pregnancy-related insomnia include cognitive behavioral therapy (CBT-I), pharmacotherapy, and acupuncture, each with varying patient perceptions.
- Understanding pregnant women's preferences is crucial for effective and patient-centered management of sleep disturbances.
Purpose of the Study:
- To ascertain pregnant women's treatment preferences for insomnia.
- To compare preferences for cognitive behavioral therapy for insomnia (CBT-I), pharmacotherapy, and acupuncture among pregnant individuals.
Main Methods:
- A cross-sectional survey was administered to 187 pregnant women recruited from a maternity clinic and a pregnancy trade show.
- Participants reviewed expert-validated descriptions of CBT-I, pharmacotherapy, and acupuncture.
- Preferences and perceptions of each insomnia treatment modality were assessed via an online questionnaire.
Main Results:
- Cognitive behavioral therapy for insomnia (CBT-I) was the most preferred treatment for insomnia among pregnant women (p < .001).
- CBT-I was rated as the most credible treatment option (partial η² = .22, p < .001).
- Participants exhibited significantly more positive reactions to CBT-I compared to pharmacotherapy and acupuncture (partial η² = .37, p < .001).
Conclusions:
- Pregnant women demonstrate a clear preference for cognitive behavioral therapy for insomnia (CBT-I) as a treatment for sleep disturbances.
- These findings align with preferences for psychotherapy in managing other conditions like depression and anxiety during pregnancy.
- Clinicians should prioritize discussing and incorporating patient preferences when developing insomnia treatment plans for pregnant individuals.
Related Concept Videos
Management of Insomnia
744
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
744
Insomnia
560
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
560
Sedatives and Hypnotics Drugs: Miscellaneous Agents
729
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
729
CNS Depressants: Barbiturates and Benzodiazepines
1.5K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K
Sedatives and Hypnotics: Overview
1.8K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.8K
Sedatives and Hypnotics Drugs: Benzodiazepines
1.1K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.1K

